J Neonatal Surg 14(3):162175 Marisetti AL, Sharma A, Tiwari A, Tiwari V, Karwasra R, Mittal V, Bhatia S, Al-Harrasi A, Khodaie L (2025) Drug discovery, commercial applications, regulations, safety and toxicity of latexes
Glucagon-like peptide-1 (GLP-1)-based therapies improve all these variables but whether the dual GLP-1 / glucose-dependent insulinotropic polypeptide (GIP) agonist tirzepatide is superior to semaglutide in attaining therapeutic targets remains unclear
Four to five small meals instead of three large ones reduces the burden on a slower stomach
These therapeutic differences may reflect distinct metabolic profiles and could act as confounders, as some antidiabetic agents might indirectly affect ocular surface homeostasis through hydration status or inflammatory pathways
Musculoskeletal and soft tissue healing depend on coordinated vascular support with resolution of inflammatory stress